Breaking News:Dangerous Delays: What Washington State (Re)Teaches Us About Cash and Cannabis Store Robberies [REPORT]

Harm Reduction

RSS Feed for this category

White House Releases 2022 National Drug Control Strategy, NH Marijuana Legalization Bill Nixed, More... (4/21/22)

A pair of companion marijuana legalization initiatives are cleared for singature-gathering in Oklahoma, SAMSHA mantains a firm line on drug testing rules, and more.

A needle exchange. The White House is emphasizing harm reduction measures to take on the overdose crisis. (Creative Commons)
Marijuana Policy

New Hampshire Senate Committee Votes to Kill Marijuana Legalization Bill. The Senate Ways and Means Committee voted unanimously Wednesday to kill a bill that would have legalized marijuana and had it sold at state-owned retail outlets, House Bill 1598. The bill could still come up for a Senate floor vote, but the committee vote likely signals the end of the road for this legislative session. The House has repeatedly passed marijuana legalization bills in recent years, only to see them die in the Senate. And even if something were to make it to the desk of Gov. Chris Sununu (R), he remains opposed to legalization. At least one senator indicated he was stuck in a time warp: "Why would we want to join the herd of introducing to our culture legalization of a substance that is unquestionably a gateway drug?" asked Sen. Bob Giuda (R-Warren).

Ohio Lawmakers File Marijuana Legalization Bill That Mirrors Ongoing Legalization Initiative. Two Democratic lawmakers, Reps. Casey Weinstein and Terrance Upchurch, have filed a marijuana legalization bill with the same language as the legalization initiative from the Coalition to Regulate Marijuana Like Alcohol (CRMTA). CRMTA's initiative passed an initial signature threshold, starting a process where the legislature has four months to either pass legalization or let it go to the voters in November (provided CRMTA succeeds in another round of signature-gathering), but there is little indication that the Republican-controlled legislature is going to act on it.

Oklahoma Marijuana Legalization Initiatives Okayed for Signature-Gathering. The state Supreme Court has cleared the way for two companion marijuana legalization initiative campaigns to begin signature-gathering. State Question 819 and the companion State Question 818, would amend the state constitution to protect the right of residents age 21 and older to use marijuana. Because they amend the constitution, they face a higher signature-gathering hurdle than State Question 820, which has already been cleared for signature-gathering. It needs about 90,000 signatures within 90 days to qualify for the ballot, while State Questions 819 and 820 will need about 178,000 valid voter signatures.

Drug Policy

Biden Administration Releases 2022 National Drug Control Strategy. The White House released the 2022 National Drug Control StrategyThursday, focusing on treating drug addiction and fighting drug trafficking. The strategy calls for expanded harm reduction interventions, such as drug test strips, needle exchanges, and access to the opioid overdose reversal drug naloxone. The new strategy is “the first-ever to champion harm reduction to meet people where they are and engage them in care and service,” the White House said. But the strategy also envisions a $300 million increase for Customs and Border Patrol and another $300 million increase for the DEA, maintaining a law enforcement emphasis. Those figures were released as part of the FY 2023 budget released last month.

Drug Testing

SAMSHA Cuts No Slack for Medical Marijuana, Accidental Exposures in Updated Federal Drug Testing Rules. In a pair of notices published in the Federal Register earlier this month, the Substance Abuse and Mental Health Services Administration (SAMSHA) published a pair of notices about proposed changes to drug testing policies. One new notice clarifies that having a doctor's recommendation for medical marijuana is not a valid excuse for a positive drug test. The secondnew notice states that passive exposure to secondhand marijuana smoke or accidental ingestion of foods containing marijuana are not a legitimate medical explanation for a positive drug test. These are proposed rules, and  there is a 60-day public comment period on the proposals is open until June 6.

NJ AG Says Cops Can Smoke Pot (But Not on Duty), ME Good Samaritan Improvement Bill Advances, More... (4/18/22)

New York issues its first marijuana grower licences, a Florida drug treatment provider is convicted of a massive drug testing fraud, and more.

There's money to be made growing weed, and in New York, equity applicants are getting the first crack at it. (CC)
Marijuana Policy

New Jersey Attorney General Says Police Can Use Marijuana Off-Duty. Marijuana use is now legal for adults in the state, and that includes police officers, Acting Attorney General Matt Platkin wrote in a memo last Thursday. The memo said it is critical for police to be clear-headed on the job, but they cannot be punished for engaging in a legal activity as long as it does not affect their work. Maybe we will see cops in line at pot shops later this week; retail sales begin on Thursday.

New York Issues First Marijuana Grower Licenses. Gov. Kathy Hochul (D) announced last Friday that the state's Cannabis Control Board has approved the first legal marijuana grower licenses in the state. The state has approved 52 Adult-Use Cannabis Conditional Cultivator licenses out of a pool of 150 applicants since March 15. The Office of Cannabis Management will continue to review applications and issue more licenses as quickly as possible. These first licenses went to "equity entrepreneurs" who qualify by having either a past marijuana conviction or one in their family and who have experience operating a successful business in the state.

Drug Testing

Florida Drug Rehab Facility Owner Guilty in Multimillion Dollar Drug Testing Fraud. Carie Lyn Beetle, the owner of Florida drug treatment center, was found guilty last Friday of running a $58 million insurance fraud scheme in which she recruited patients by offering free or discounted rent and free travel to Florida to stay in her sober houses, then tested them as often as three times a week, for which she would submit insurance claims. The frequency of the testing, for which she could bill as much as $5,000 each time, was considered unnecessary, and the results were not studied by treatment professionals. Sometimes the tests were never even conducted, but still billed for. Her center, Real Life Recovery, would also often bill for counseling and treatment services that were not actually conducted, and employees testified that they would regularly forge patient signatures to show they had attended counseling when they had not. For turning her treatment program into a racket, Beetle is now looking at up to 30 years in prison.

Harm Reduction

Maine Senate Approves Strengthened Good Samaritan Law. The Senate last Friday approved a bill to strengthen the state's Good Samaritan law, which is designed to protect people suffering from overdoses and those seeking to help them from prosecution. The bill, LD 1682, would change the existing law so that any person at the scene of an overdose who makes a good faith effort to call for assistance is protected from arrest or prosecution. The bill would include immunity for bail and probation violations, while exempting sex crimes, crimes involving children, and arson, among other crimes. It now heads to the House. 

Lawmakers Press Drug Companies on Over-the-Counter Naloxone, Dem Voters Say Legal Pot a Priority, More... (4/13/22)

New polls of American and European voters show support for marijuana legalization, Massachusetts prisoners are suing over unreliable drug tests, and more. 

The opioid overdose reversal drug naloxone. Lawmakers want drug companies to seek over-the-counter status for it.
Marijuana Policy

Majority of Democrats Say Marijuana Legalization Should Be a Top Priority for Congress. A new poll from Morning Consult and Politico finds that more than half (52 percent) of Democratic voters say marijuana legalization should be a top or important priority for Congress. Only 29 percent of Republican voters felt the same. Overall, 41 percent of voters now see marijuana legalization as a top or important congressional priority. The poll comes with the House having already passed a marijuana legalization bill and with the Senate waiting on Majority Leader Chuck Schumer (D-NY). Meanwhile, desperately needed interim measures, such as providing industry access to financial services, languish.

Drug Testing

Massachusetts Prisoners Sue Over Prison System's "Unreliable" Drug Tests Despite Court Order. Attorneys representing state prisoners have filed a lawsuit against the Department of Correction charging that it continues to use an unreliable drug test to screen prisoners' mail, violating an earlier court order. The lawsuit alleges that prisoners have been punished for sneaking drugs through the mail based on dubious drug tests and that some of the mail improperly seized as containing drugs were sent by the prisoner's own attorneys, the courts, and the attorney general's office. A judge last December ordered the department to quit using the NARK II drug test device. The attorneys are asking a judge to hold the department in contempt of court. A hearing is set for next Tuesday. "The DOC's actions were not only interfering with the attorney-client relationships of the people whose mail was seized and photocopied, but were chilling the ability of all incarcerated people to communicate with counsel for fear of being subjected to this arbitrary and severe punishment," the complaint said.

Harm Reduction

Bipartisan Lawmakers Call on Drug Makers to Apply to FDA to Make Overdose Reversal Drugs Available Over-the-Counter. Some 30 members of the House and Senate have sent a letter to drug companies who manufacture the opioid overdose reversal drug naloxone calling on them to apply to the Food and Drug Administration (FDA) for over-the-counter status for their products. The move comes amidst a raging opioid overdose epidemic that is killing tens of thousands of Americans each year. "It has never been more important to adopt opioid overdose prevention and reversal strategies on a wide scale," the letter said. This includes "steps to increase access to affordable naloxone, which is a proven, effective tool to reduce medical emergencies, drug overdoses, and deaths." Signatories included Sens. Joe Manchin (D-WV), Elizabeth Warren (D-MA), and Lisa Murkowski (R-AK) and Reps. Alexandria Ocasio-Cortez (D-NY) Rashida Tlaib (D-MI), and Brian Fitzpatrick (R-PA).

International

Poll Found Majority of Europeans Support Marijuana Legalization. A poll from  London-based Hanway Associates that surveyed eight different European countries found majority support for marijuana legalization, with 55 percent favoring it and only 25 percent opposing it. Italy led the way with support at 60 percent. Portugal, Switzerland, Spain, and the United Kingdom all polled between 55 and 59 percent, while Germany came in at 50 percent. Surprisingly, the Netherlands, which has allowed legal retail sales for more than 30 years, had the lowest level of support, at 47 percent. 

DOJ Issues Guidance on Legal Protections for People on MAT, NJ Recreational Pot Sales Coming Soon, More... (4/12/22)

An Oklahoma psychedelic research bill advances minus a decriminalization provision, Mississippi regulators roll out initial guidelines for the state's medical marijuana programs, and more.

The DOJ issues guidance on legal protections for people undergoing medication-assisted treatment. (Creative Commons)
Marijuana Policy

New Jersey Regulators Okay First Recreational Marijuana Sales. The state's Cannabis Regulatory Commission on Monday opened the way to recreational marijuana sales by approving seven medical marijuana dispensaries to sell to anyone 21 or over. The commission's executive director, Jeff Brown, said retail licenses could be issued within a month, once dispensaries pay fees and undergo compliance checks. The move comes more than a month after the state blew through a February 22 deadline for dispensaries to begin selling to adults. The commission had been concerned about maintaining adequate supplies for patients, but those concerns seem to have been assuaged. "All of the (dispensaries) here, we believe have proven and have shown that they have adequate supply for their medical patients, that they are willing to put in place the necessary mechanisms to protect that supply, and ensure that medical patients are not impacted,” Brown said.

Medical Marijuana

Mississippi Medical Marijuana Program Rules and Regulations Released. The state Health Department on Monday released preliminary rules and regulations for the state's nascent medical marijuana program. These beginning measures address qualifying conditions, obtaining registry and identification cards, and how to certify as a practitioner, among other things. The list of qualifying conditions includes cancer, Parkinson’s, Huntington’s, muscular dystrophy, glaucoma, spastic quadriplegia, HIV, AIDS, hepatitis, amyotrophic lateral sclerosis (ALS), Crohn’s, ulcerative colitis, sickle cell anemia, Alzheimer’s, agitation of dementia, PTSD, autism, pain refractory to opioid management, diabetic/peripheral neuropathy, spinal cord disease, or severe injury; chronic medical treatment that causes cachexia or wasting, severe nausea, seizures, severe and persistent muscle spasms, or chronic pain. Patients may only get recommendations from doctors with whom they have an existing relationship and will pay $25 for a 1-year ID card. Those applications will be available on or before June 2.

Psychedelics

Oklahoma Senators Approve Psilocybin Research Bill but Remove Decriminalization Language Approved by House. The Senate Health and Human Services Committee voted unanimously Monday to approve a bill passed by the House that would allow eligible research and medical institutions to cultivate and administer psilocybin for research purposes, but only after amending it to remove a provision that decriminalized the possession of the drug. House Bill 3414 "came over [from] the House—it had some decriminalization elements in there," Sen. Lonnie Paxton (R) said on Monday, adding that lawmakers had "worked a lot with it, trying to make sure that we clean it up." They did that by erasing the decriminalization provision. “That no longer exists," he said. "This is just for a university study."

Drug Treatment

US Department of Justice Issues Guidance Concerning Legal Protections for Individuals Recovering from Opioid Use Disorder. The Justice Department published guidance last week explaining how the Americans with Disabilities Act (ADA) protects people who are in treatment or recovery for opioid use disorder (OUD), including those who take prescription medications as part of that treatment. The guidance says those people are considered disabled under the ADA, that they may be prescribed medications such as methadone, buprenorphine, and naltrexone, among others; and that employers may not discriminate against them if they are in treatment and using those drugs. The guidance also notes that while employers may conduct drug testing, they may not fire or refuse to hire people legally using those medications—unless the use renders the person unable to safely or effectively perform the job. DOJ said the guidance "is part of the department’s comprehensive response to the opioid crisis, which promotes prevention, enforcement and treatment" and lists several civil rights lawsuits it is pursuing over such discrimination.

Amendments Fly as House Legal Pot Vote Looms, Singapore Hangs Man for Drug Trafficking, More... (3/30/22)

A Maryland marijuana legalization bill advances, New Mexico pot shops will open starting Friday, a Georgia therapeutic psychedelic study bill advances, and more.

The House is set to vote on the MORE Act this week. (Creative Commons)
Marijuana Policy

Lawmakers File Various Amendments to House Marijuana Legalization Bill. With a House floor vote on the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act (HR 3617) set for this week, proposed amendments are coming fast and furious. They will be taken up by the House Rules Committee Wednesday. Most of the proposed amendments seek to impose restrictions on the bill, such as requiring completion of various certain studies before legalization, limiting expungement provisions, or maintaining certain penalties. One, though, would provide relief for people denied security clearances because of past marijuana convictions.

Maryland Marijuana Legalization Bill Advances. The Senate Finance Committee on Tuesday approved a marijuana legalization bill, Senate Bill 833, that would only take effect if voters approved a related ballot question in November. A slightly different version of the bill passed the House last month, so a conference committee will have to hash out the differences. The panel did not act on House Bill 1, which would establish the November referendum. The legislature faces a deadline at the end of the week. Lawmakers will only have the chance to override a possible veto by Gov. Larry Hogan (R) if they get bills to his desk this week.

New Mexico Recreational Pot Shops Can Open Their Doors on Friday. The state legislature legalized marijuana last year, and beginning on Friday, the first recreational marijuana sales in the state can begin. New Mexicans could legally possess and use marijuana since last June, but had no place to legally purchase recreational marijuana—until now. State officials have issued more than 200 licenses for retail pot shops. When they open later this week, adults will be able to purchase two ounces of weed at a time.

Opiates and Opioids

California Fentanyl Crisis Prompts Flurry of Bills. Lawmakers are responding to a surge in fentanyl-related overdoses with a number of bills, some punitive, but others embracing harm reduction interventions. Assembly Member Cottie Petrie-Norris (D-Irvine) has filed Assembly Bill 2246, which would increase penalties for possession and distribution, including a sentence of 20 years to life for someone who sold fentanyl that resulted in a fatal overdose. Assembly Member James Ramos (D-Highland) has field Assembly Bill 1628, which would require companies such as Snapchat to implement policies that prohibit the sale of fentanyl and other controlled substances on their platforms. Senate Bill 864 would require hospitals to test drug screening urine samples for fentanyl, Senate Bill 1350 would require warnings to people convicted of drug distribution offenses that they could be charged with manslaughter of murder in the event of a fatal overdose, while Assembly Bill 1673 would set up a California Fentanyl Task Force to produce statewide statistics and ramp up public awareness. On the harm reduction side, Sen. Scott Weiner's (D-San Francisco) Senate Bill 57 would authorize pilot safe injection site program in San Francisco, Oakland, and Los Angeles. That bill has passed the Senate and is now before the Assembly Public Safety Committee.

Psychedelics

Georgia Therapeutic Psychedelic Study Bill Advances. The House Appropriations Public Safety Subcommittee voted Tuesday to approve House Resolution 896, which would create a House study committee to investigate the therapeutic potential of psychedelics such as psilocybin and make recommendations for legislation. The bill is couched as an effort to address the need for effective treatments for depression and PTSD for military veterans. It now heads to the House Defense and Veteran Affairs Committee.

International

Colombia Coca Zone Battle Sees 11 FARC Dissidents Killed. The Colombia Army said Tuesday its soldiers had killed at least 11 FARC dissidents in open combat n Puerto Leguizamo municipality in Putumayo province near the borders with Ecuador and Peru. The area has extensive coca plantings and cocaine-producing laboratories and is contested by various armed actors. The FARC dissidents are former members of the Revolutionary Armed Forces of Colombia (FARC), who rejected the FARC's demobilization under a 2016 peace deal with the government.

Mexico Attack Leaves at Least 20 Dead in Michoacan. Presumed cartel gunmen attacked spectators at a cockfighting pit in the town of Las Tinajas Sunday, leaving at least 20 people dead and several more wounded. "It was a massacre of one group by another," President Andres Manuel Lopez Obrador told a news conference, expressing his regret at the deaths. The state of Michoacan and neighboring Guanajuato have been plagued by cartel violence for years, with the most recent mass killing leaving 17 people dead only weeks ago. Earlier this month, the mayor of Aguilla, Michoacan, was gunned down, and days later, journalist Armando Linares was killed in Zitacuaro. Most of the violence is between the Jalisco New Generation Cartel and local gangs, but some of it is between different factions of that same cartel.

Singapore Hangs Man for Drug Trafficking. Closing its ears to pleas for leniency, including from the UN Human Rights Office, Singapore on Wednesday executed Abdul Kahar Othman, 68, for drug trafficking. The hanging marked the first execution in the country since it halted them due to the coronavirus pandemic. The last execution took place in November 2019. Kahar, from a poor family, had struggled with addiction all his life and spent much of his adult life behind bars. He was convicted of drug trafficking in 2013. Another execution may be looming. A Malaysian man with mental disabilities, Nagaenthran K. Dharmalingam, has been on death row since 2010 for trying to smuggle 1.5 ounces of heroin into the city-state. He lost his final appeal on Tuesday. 

MA Drug Courts Agree to Allow Medication-Assisted Treatment, CT Psychedelic Treatment Bill Advances, More... (3/28/22)

Illinois Senate Democrats roll out a pair of bills to fight the opioid overdose crisis, South Dakota's governor vetoes a bill removing old pot charges from public background checks, and more.

Buprenorphine. This and other Medications for Opioid Use Disorder will now be allowed in Bay State drug courts. (CC)
Marijuana Policy

South Dakota Governor Vetoes Bill to Automatically Remove Old Marijuana Charges from Background Checks. Gov. Kristi Noem (R) has vetoed Senate Bill 151, which would have automatically removed marijuana charges and convictions more than five years old from public background checks. The bill also required that past offenders have fulfilled their sentences and have no later arrests. In her veto statement, Noem said, "It also essentially codifies a convicted person's ability to be dishonest about their previous arrest and conviction by not requiring disclosure of the prior drug conviction." The bill did not pass with veto-proof majorities.

Psychedelics

Connecticut Lawmakers Advance Psychedelic-Assisted Treatment for Veterans. A bill that would allocate $3 million to help veterans and other disadvantaged people gain access to psychedelic-assisted therapies is advancing. House Bill 5396 passed the Public Health Committee on a unanimous vote last Friday and has now been referred to the Office of Legislative Research and Office of Fiscal Analysisprior to a House floor vote.

Drug Courts

Feds Reach Settlement with Massachusetts Drug Court Over Discriminating Against People with Opioid Use Disorder. The US Attorneys Office in Boston announced last Thursday it had reached an agreement with the Massachusetts Trial Court to resolve charges its drug court discriminated against people with Opioid Use Disorder, violating the Americans with Disabilities Act. Federal prosecutors argued that the drug court discriminated against people taking Medications for Opioid Use Disorder (MOUD), such as buprenorphine, methadone, and naltrexone, by barring or pressuring them to stop using those medications in order to participate in the drug court program. Under the new agreement, all 25 state drug courts will allow the use of MOUDs, with decisions about their use taken only by licensed practitioners or licensed opioid treatment programs. "The opioid crisis has impacted nearly every household and family unit in the Commonwealth. My family is no exception. Sadly, in Massachusetts per capita rates of opioid-related deaths are above the national average. To combat this public health crisis we need to be doing everything possible to save lives. That includes ensuring access to all forms of medical treatment for OUD," said United States Attorney Rachael S. Rollins. "We commend the Massachusetts Trial Court for working with us to implement a policy that sets a standard for other state courts across our country to follow. This policy helps ensure that the court system leaves MOUD treatment decisions to trained and licensed medical professionals."

Harm Reduction

Illinois Democrats Roll Out Pair of Bills to Address Overdose Crisis. Senate Democrats last Thursday unveiled a pair of bills that take aim at the state's opioid overdose crisis, where deaths related to synthetic opioids have increased nearly 25-fold since 2013. Sen. Laura Ellman (D-Naperville) is the Senate sponsor of House Bill 17, a Good Samaritan law that would grant immunity from prosecution for possession of small amounts of fentanyl that for people suffering from an overdose or for people seeking to aid them. And Sen. Robert Peters (D-Chicago) is the Senate sponsor of House Bill 4556, which would allow pharmacists and medical professionals to dispense fentanyl test strips and other drug-testing supplies to anyone who wants them. adulterant testing supplies to any person without persecution for possessing drug testing supplies.

Chronicle Book Review: "Transforming the War on Drugs" [FEATURE]

Transforming the War on Drugs: Warriors, Victims and Vulnerable Regions edited by Annette Idler and Juan Carlos Garzon Vergara (2021, Oxford University Press, 584 pp., $34.95 PB)

If you have been watching the growing fissures and fractures in the global prohibitionist consensus embodied in the United Nation's three-treaty international drug control regime (IDCR) and are expecting the whole thing to come crashing to the ground sometime soon, don't hold your breath. That is the message that comes through loud and clear in Transforming the War on Drugs, an essential collection that comprehensively analyzes the past and present of global drug policy and points the way to a different, better future.

As the contributors make clear, while the IDCR is suffering well-earned stresses, especially around its failure to succeed on its own terms -- reducing drug use and the drug trade -- and while the "Vienna consensus" may be fraying, the global reform movement that has been building since the failure of the 1998 UN General Assembly Session (UNGASS) on Drugs to meet its goal of eradicating drug use within a decade has yet to jell.

As Monica Serrano explains in "A Forward March Halted: The UNGASS Process and the War on Drugs," while Latin American nations such as Colombia and Mexico called for a reconsideration of the IDCR, paving the way for the 2016 UNGASS, they did not succeed in building alliances with other nations that could push the process forward. That was not only because of deficiencies in those countries' efforts, but also because, despite the ever-increasing calls for change, a majority of countries around the world still subscribe to the law enforcement-heavy tenets of the global drug prohibition regime.

That is despite the now quite clearly understood harms that the IDCR imposes on different countries and groups around the world. Whether it is enabling the rise of violent drug trafficking organizations, destroying the livelihoods of poor drug crop farmers, creating horrendous human rights violations, filling prisons around the world, or creating needless suffering for drug users, the international response to drug use and trafficking is creating real, calculable negative consequences.

As coeditor Annette Idler demonstrates in "Warriors, Victims, and Vulnerable Regions," the heedless harshness of the IDCR is embedded in its very DNA. From the beginning, the US "war on drugs" model and the rhetoric of drugs as "evil" and an existential threat to the security of nation-states has excused the sort of "state of emergency" measures -- criminalization, law enforcement crackdowns, militarization -- that, while not even managing to make countries more secure, manages to bring not security but insecurity to communities and drug using individuals.

Other contributors to the volume make that point in great detail in case studies of Latin America, Mexico and the Caribbean, West Africa, the Crescent (Afghanistan, Iran, Pakistan), the Golden Triangle, and Russia. How can one argue that drug prohibition has brought security to Mexico, with thousands of killings each year and police forces so corrupted you don't know which department is working for which cartel? Likewise, West Africa, where drug prohibition has so corrupted some governments that "the state becomes a threat to its own self"?

Given current events, the case of Russia is particularly interesting. It is one of the staunchest supporters of the current IDCR, but not just because of its inherent authoritarianism. Russia didn't really have a significant drug control regime until the post-Soviet era of the 1990s, and then it modeled its apparatus on that of the DEA. But even though it looked to the West for drug war expertise, its drug concerns were primarily domestic: It has one of the world's most serious heroin problems, one driven by supply rather than demand, contributor Ekaterina Stepanova explains. That supply is coming from Afghanistan, and Russian addicts account for about one quarter of all Afghan heroin production. One more reason for Russia to be unhappy with the US and NATO, who, in two decades of occupying Afghanistan, never effectively suppressed the poppy crop.

One of the more fascinating chapters is on rethinking the metrics of measuring success in drug policy. Instead of measuring "securitized" items such as acres of drug crops eradicated, the amount of drugs seized, the number of traffickers arrested -- all of which really measure repressive enforcement activity -- contributors Robert Muggah and Katherine Aguirre argue for new metrics for a new framework for evaluating drug policies. With broad goals of improving the health and welfare of the population and enhancing the safety and security of people who use drugs and the broader public, instead of measuring busts and seizures, we should be quantifying metrics for decriminalizing drug use (is it decriminalized, how many legislative measures are aimed at it, how many civil society groups are involved, how many people are being arrested and imprisoned) and curbing drug harms through public health measures (number of drug overdose deaths, number of other drug-related deaths, prevalence of drug-linked infectious disease). This really make sense if we are actually interested in improving lives as opposed to the quixotic quest to eliminate drug use.

There is a whole lot more to this volume. It is a comprehensive, systematic effort to theoretically, conceptually, and empirically investigate the effects of the IDCR and offer a more human alternative. Anyone seriously interested in working to understand and change the global drug prohibition regime need a well-thunbed copy of this on his bookshelf.

DEA Commits to Expanding Medication-Assisted Treatment, Human Rights Watch Calls for End to US Pot Prohibition, More... (3/23/22)

Rhode Island lawmakers are trying to thrash out agreement on a marijuana legalization bill, the Marijuana Policy Project releases a report on the states lagging behind on marijuana reform, and more.

Buprenorphine. The DEA says it is commited to expanding medication-assisted treatment (MAT), such as bupe. (Pixabay)
Marijuana Policy

Human Rights Watch Calls on US to End Marijuana Prohibition Now. Human Rights Watch is calling on the federal government to legalize marijuana as "a much-needed move toward a US drug policy grounded in human rights, harm reduction, and health." The group noted that in the last Congress, the House passed the historic Marijuana Opportunity Reinvestment and Expungement (MORE) Act and said a House floor vote on this year's version of the bill, HR 3617 is "an urgent step toward advancing long overdue reforms in the criminal justice system and beyond." It also called on members of Congress to "heed the call of a diverse coalition of organization and cosponsor the bill. House leadership should immediately bring the bill to a floor vote," the group said.

Marijuana Policy Project Releases Report on the States Lagging Behind on Marijuana Reform. Recognizing the 50-year anniversary of the report issued by the Shafer Commission, which investigated the effects of cannabis use on specific communities and found that small amounts of cannabis do not harm society and should not result in criminalization or jail time, the Marijuana Policy Project (MPP) released a new report on Tuesday, Behind the Times: The 19 States Where a Joint Can Still Land You in Jail. The report examines the laws that lag the furthest behind public opinion: the 19 states and federal government, which have not even "decriminalized" simple possession of cannabis. In those states, it examines penalties for simple possession, arrest rates, and racial disparities in arrests and provides a glimpse at some of the damage inflicted by draconian laws. It also reviews unsolved crime rates in the states that continue to use limited law enforcement resources to arrest and jail adults for possessing a substance that is safer than alcohol.

Rhode Island Lawmakers Meet to Ponder Competing Marijuana Legalization Proposals. The House Finance Committee met on Tuesday to discuss competing marijuana legalization proposals from the House and Senate leadership and Gov. Dan McKee (D). McKee proposed a legalization plan in his budget package, House Bill 7123, while the legislative leaders are backing Senate Bill 2430. At the hearing, advocates complained of inadequate equity provisions in the Senate bill, with members saying they were open to feedback. The governor's bill on the other hand, has provisions to automatically expunge past convictions.

Drug Treatment

DEA Commits to Expanding Access to Medication-Assisted Treatment. DEA Administrator Anne Milgram on Wednesday announced the Drug Enforcement Administration’s continued commitment to expanding access to medication-assisted treatment to help those suffering from substance use disorder. "In this moment, when the United States is suffering tens of thousands of opioid-related overdose deaths every year, the DEA’s top priority is doing everything in our power to save lives," said Administrator Milgram. "Medication-assisted treatment helps those who are fighting to overcome substance use disorder by sustaining recovery and preventing overdoses. At DEA, our goal is simple: we want medication-assisted treatment to be readily and safely available to anyone in the country who needs it." The agency has recently been championing a number of initiatives to expand access to medication-assisted treatment for those suffering from opioid-related substance use disorder, including a loosening of restrictions around buprenorphine and methadone prescribing, reaching out to pharmacists and practitioners to let them know DEA supports medication-assisted treatment, and increasing the number of mobile methadone clinics. 

VT House Approves Bill to Cut Drug Sentencing, FL House Republicans Kill Fentanyl Test Strip Bill, More... (3/22/22)

A New Hampshire marijuana legalization bill takes another key step toward passage, there's a push for drug decriminalization in Maine, and more.

More states are taking up bills to legalize fentanyl test strips in a bid to reduce overdoses. (Creative Commons)
Marijuana Policy

New Hampshire House Committee Approves Marijuana Legalization Bill; It Now Heads for Second House Floor Vote. A bill to create a legal marijuana market through state-run dispensaries that has already passed the House once has now been amended and approved by the House Ways and Means Committee, which took it up because it involved economic components. The bill, House Bill 1348, is now set for a second House floor vote, and if the amended measure is approved, will then head t the Senate.

Drug Policy

Maine ACLU, Center for Economic Policy Release Report Calling for Drug Decriminalization. The Maine chapter of the ACLY and the Maine Center for Economic Policy (MECEP) released a report Monday recommending the decriminalization of drug use and possession in the state, A Better Path for Maine: The Case for Decriminalizing Drugs. The report highlights the cost of criminalizing drug use, the impact on incarcerated individuals for drug possession and use, and challenges with the legal system associated with drug criminalization. "In addition to the very real toll that the war on drugs inflicts on Mainers' physical and mental wellbeing, collectively we pay millions of dollars each year in financial costs," James Myall, an economic policy analyst at MECEP, said. "Year over year, Maine has prioritized incarcerating and criminalizing people who use drugs over making treatment for drug use more available. Not only is this approach ineffective, but it's extremely costly."

Vermont House Approves Bill to Cut Maximum Drug Sentences, Review Laws on Drug Possession. The House last Friday approved House Bill 505, which would cut maximum sentences for drug offenses and set up a board to review existing drug possession laws. The bill drops some drug offenses, such as possession of small amounts of heroin, from felonies to misdemeanors. It also eliminates the sentencing disparity between crack and powder cocaine. It would also create a Drug Use Standards Advisory Board, a move first proposed in House Bill 644, a broader bill that would decriminalize drug possession but which has failed to move out of the House Judiciary Committee.

Harm Reduction

Florida House Republicans Kill Bill to Legalize Fentanyl Test Strips. A bill to legalize fentanyl test strips as part of the effort to reduce drug overdose deaths in the state was killed earlier this month by House Republicans. The bill had passed out of the Senate as part of broader legislation, but when it came before the House on March 11, the last day of the session, the Republicans who control the House voted on a voice vote to strip the fentanyl test strip language from the broader bill, which they then passed.

Tennessee Legislator Approves Bill Legalizing Fentanyl Test Strips. Both chambers of the legislature have approved a bill that would remove fentanyl test strips from the state's definition of illegal drug paraphernalia, House Bill 2177. Legislators were moved to act after fentanyl overdose deaths jumped 46 percent between 2018 and 2019 and more than 700 people died of drug overdoses in Nashville alone last year. "If we can save one life, I think that this bill is worth it, because overdose cases are out of control," said Sen. Raumesh Akbari (D-Memphis). "If we can help them at least not take something that could kill them — one pill and it could kill — then that’s what I want to be able to do." The bill

now goes to the desk of Gov. Bill Lee (R). A spokesperson said he plans to sign it into law.

CA Psilocybin Legalization Initiative Falls Short on Signatures, Ukraine War Deepens Suffering of Drug Users, More... (3/18/22)

Medical marijuana bills advance in Georgia and Kentucky, Honduras' former "narcopresidente" is a step closer to being extradited to the United States on drug charges, and more. 

Fomer Honduran President Juan Orlando Hernandez can be extradited to face US drug charges, a court there ruled. (CC)
Marijuana Policy

Rhode Island Governor Has "Concerns" About Marijuana Legalization Bill's Cannabis Control Commission. Gov. Dan McKee (D) has "significant constitutional concerns" with Senate Bill 2430, the marijuana legalization bill backed by House and Senate leadership. The concerns are around the proposed three-member cannabis control commission's members are to be appointed—and removed if necessary. The governor's office argues that the bill would give the Senate "unfettered discretion" on whether to remove a commissioner, which is says is a violation of the separation of powers. But one of the key sponsors of the bill, which was crafted after long deliberation, Sen. Joshua Miller (D-Cranston), said the governor's objection is not an insurmountable obstacle. "It’s not a big impediment," said Miller. "It’s solvable." 

Medical Marijuana

Georgia House, Senate Pass Separate Medical Marijuana Bills. The House approved a bill to revamp the state's dysfunctional medical marijuana system, House Bill 1425 on Tuesday. The bill would allow the provision of low-THC cannabis oil "from any available legal source" by August 1 and begin providing it to patients now on the state registry by August 15. The state had passed a low-THC cannabis oil law in 2015, but legal challenges have left Georgians without any legal supply. The Senate, meanwhile, approved its own medical marijuana bill, Senate Bill 609, which would require the medical cannabis commission to issue its initial licenses by May 31. Tuesday was the last day for bills to pass their original chamber, so both bills remain alive.

Kentucky House Approves Medical Marijuana Bill. The House on Thursday approved House Bill 136, which would legalize medical marijuana in the state. The legislation now heads to the Senate. This is the third try for bill sponsor Rep. Jason Nemes (R), who got a similar bill through the House in 2020 only to see in die in the Senate and whose 2021 effort got nowhere in the midst of the pandemic. The bill now heads to the Senate, where Senate Judiciary Chairman Whitney Westerfield (R) says he will back it despite personal reservations.

Psychedelics

California Psilocybin Legalization Initiative Falls Short on Signatures. Decriminalize California, the group behind a psilocybin legalization initiative campaign, announced Wednesday that it had failed to gather enough valid voter signatures to qualify for the November ballot. The all-volunteer effort faltered during the winter outbreak of the omicron variant of the coronavirus. "We were doing great there collecting and then in mid-December just about everyone of our core volunteers got COVID and most of the events we were scheduled at either closed, postponed or had an extremely weak turnout," campaign manager Ryan Munevar said in an email to supporters. The group will now do fundraising in coming months to determine whether it is feasible to start a second effort in either June or October of next year for 2024.

International

At Urging of US, CND Acts Against Precursor Chemical Used to Produce Illicit Fentanyl. The UN Commission on Narcotic Drugs (CND) voted Friday to control three chemicals used by drug traffickers to produce illicit fentanyl, a powerful synthetic opioid that is driving overdose deaths in the United States. At the request of the United States, and with the recommendation of the International Narcotics Control Board, the Commission’s Member States voted unanimously to take international action and control the acquisition, production, and export of three precursors used to manufacture illicit fentanyl and its analogues. "President Biden has made clear that ending the overdose epidemic is a top priority. As part of the Administration’s efforts to reduce the supply of illicit fentanyl driving overdose deaths, the United States called on the global community to regulate three chemicals commonly used to produce it, and today that call was answered," said Dr. Rahul Gupta, Director of the White House Office of National Drug Control Policy (ONDCP). "This new action makes it more difficult for drug traffickers to obtain and use these chemicals for illicit purposes. It will also help disrupt synthetic drug trafficking that not only leads to deaths caused by overdose, but also corruption, drug-related violence, and insecurity. The collective work of the international community to address global drug-related challenges has never been more important. The Biden-Harris Administration is committed to building on today’s progress."

Honduran Judge Okays Extradition of Former President to Face US Drug Charges. A judge in Honduras has ruled the former President Juan Orlando Hernandez can be extradited to the United States to face drug charges. Hernandez was president from 2014 until last month, after he lost an election, and was considered a US ally even though federal prosecutors alleged he was involved in drug trafficking throughout his presidency. He was detained last month by the new government at the request of the US. The "narcopresidente" has until Saturday to appeal the Wednesday ruling, after which he could be extradited. Meanwhile, he remains in prison in Honduras.

War Deepens Suffering for Ukraine's Drug Users. Drug users in the country are facing shortages of methadone and street drugs as the Russian military campaign in the country disrupts daily life. "Today, I went around five pharmacies where I used to get methadone on prescription. None were open. Another place was open today, but there was a queue of at least 200 people and I didn’t want to go into withdrawal right there, and so I went home," one drug user said. In the city of Kyiv, there were 45 fee-based centers serving opioid-dependent patients each; now they are all closed after the doctors evacuated. Similar clinics in the Crimean Peninsula were shut down when Russian forces took over in 2014; since then, of approximately 800 Crimean methadone patients, at least 80 have killed themselves, died of fatal overdoes, or died of other narcotic causes. 

Drug War Issues

Criminal JusticeAsset Forfeiture, Collateral Sanctions (College Aid, Drug Taxes, Housing, Welfare), Court Rulings, Drug Courts, Due Process, Felony Disenfranchisement, Incarceration, Policing (2011 Drug War Killings, 2012 Drug War Killings, 2013 Drug War Killings, 2014 Drug War Killings, 2015 Drug War Killings, 2016 Drug War Killings, 2017 Drug War Killings, Arrests, Eradication, Informants, Interdiction, Lowest Priority Policies, Police Corruption, Police Raids, Profiling, Search and Seizure, SWAT/Paramilitarization, Task Forces, Undercover Work), Probation or Parole, Prosecution, Reentry/Rehabilitation, Sentencing (Alternatives to Incarceration, Clemency and Pardon, Crack/Powder Cocaine Disparity, Death Penalty, Decriminalization, Defelonization, Drug Free Zones, Mandatory Minimums, Rockefeller Drug Laws, Sentencing Guidelines)CultureArt, Celebrities, Counter-Culture, Music, Poetry/Literature, Television, TheaterDrug UseParaphernalia, Vaping, ViolenceIntersecting IssuesCollateral Sanctions (College Aid, Drug Taxes, Housing, Welfare), Violence, Border, Budgets/Taxes/Economics, Business, Civil Rights, Driving, Economics, Education (College Aid), Employment, Environment, Families, Free Speech, Gun Policy, Human Rights, Immigration, Militarization, Money Laundering, Pregnancy, Privacy (Search and Seizure, Drug Testing), Race, Religion, Science, Sports, Women's IssuesMarijuana PolicyGateway Theory, Hemp, Marijuana -- Personal Use, Marijuana Industry, Medical MarijuanaMedicineMedical Marijuana, Science of Drugs, Under-treatment of PainPublic HealthAddiction, Addiction Treatment (Science of Drugs), Drug Education, Drug Prevention, Drug-Related AIDS/HIV or Hepatitis C, Harm Reduction (Methadone & Other Opiate Maintenance, Needle Exchange, Overdose Prevention, Pill Testing, Safer Injection Sites)Source and Transit CountriesAndean Drug War, Coca, Hashish, Mexican Drug War, Opium ProductionSpecific DrugsAlcohol, Ayahuasca, Cocaine (Crack Cocaine), Ecstasy, Heroin, Ibogaine, ketamine, Khat, Kratom, Marijuana (Gateway Theory, Marijuana -- Personal Use, Medical Marijuana, Hashish), Methamphetamine, New Synthetic Drugs (Synthetic Cannabinoids, Synthetic Stimulants), Nicotine, Prescription Opiates (Fentanyl, Oxycontin), Psilocybin / Magic Mushrooms, Psychedelics (LSD, Mescaline, Peyote, Salvia Divinorum)YouthGrade School, Post-Secondary School, Raves, Secondary School